Receptor-targeted nanoparticles modulate cannabinoid anticancer activity through delayed cell internalization
Abstract Δ9-tetrahydrocannabinol (Δ9-THC) is known for its antitumor activity and palliative effects. However, its unfavorable physicochemical and biopharmaceutical properties, including…